Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipoic Acid for Glycaemic Control in Type 2 Diabetes
NCT00398892Phase 2Withdrawn
- Sponsor
- University of Edinburgh
- Start
- Dec 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of alpha-lipoic acid in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University of Edinburgh. Primary endpoint: Change in HbA1c at 12 weeks. Planned start Dec 2009; status: withdrawn.
02
Drugs
alpha-lipoic acid
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00398892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00398892.